Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in ...

Max, formerly known as HBO Max, officially has a new logo on Sunday night, March 30. The new logo for Warner Bros. Discovery's steaming platform was unveiled on Sunday evening. The new logo gives ...

Looking at the PGA Tour’s career money list to determine the relative success of a player’s career is mostly a futile endeavor. Sure, Tiger Woods at No. 1 with $120-plus million makes sense ...

‘There is nothing you could have done, because this was my decision to go to Switzerland and be in peace… I can’t keep going and get older and older without my son.’ Judith Hamilton learnt ...

Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or Pneumococcal 21-valent Conjugate Vaccine, for active ...

“Ghost guns are the gun industry’s way of skirting commonsense gun laws and arming dangerous people without background checks,” said David Pucino, legal director and deputy chief counsel of ...

With Ranging Mode (R-Mode), the German Aerospace Center DLR is working with partners to develop an alternative to satellite-based navigation systems. R-Mode uses existing infrastructures of ...

Merck & Co. is handing over $200 million to China’s Hengrui Pharma for a phase 2-stage lipoprotein(a) (Lp(a)) inhibitor. In return for the ex-China rights to the drug, dubbed HRS-5346, Merck has ...

(Reuters) -Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, the latest in a series of deals U.S. drugmakers have ...